Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice-Reference-Cited by-同舟云学术

Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice

Published:2022 Issue:1 Volume:13 Page:102-112
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Li Bei¹,Zhang Haibo²,Shi Linlin³,Li Rong¹,Luo Yanan¹,Deng Yun¹,Li Shihan⁴,Li Ruizhen⁴,Liu Zhi¹^ORCID

Affiliation:

1. Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, P. R. China

2. Hubei Provincial Key Laboratory of Yeast Function, Yichang, P. R. China

3. Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital (College of Clinical Medicine) of Henan University of Science and Technology, Luoyang, P. R. China

4. Department of Children Healthcare, Wuhan Children's Hospital, Wuhan Maternal and Child Healthcare Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan, P. R. China

Abstract

The probiotic Saccharomyces boulardii relieved intestinal barrier dysfunction and inflammation in a gut microbiota-dependent manner.

Funder

National Key Research and Development Program of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D1FO02752B

Reference49 articles.

1. The global burden of IBD: from 2015 to 2025